Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Medical Cannabis topic

No spam. Unsubscribe anytime.

Board upholds permit for Mission Organics dispensary at 5258 Mission amid intense neighborhood debate

San Francisco Board of Appeals · June 20, 2012
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

After a packed public hearing with dozens of neighbors testifying for and against, the Board of Appeals denied an appeal of a Department of City Planning permit and upheld a site permit for a medical‑cannabis dispensary at 5258 Mission Street, finding the permit complied with current code and distinguishing the case from a prior Taraval decision. The vote was 3–1.

The San Francisco Board of Appeals on June 20 denied an appeal and upheld a planning commission approval and DBI site permit for a medical cannabis dispensary (Mission Organics) at 5258 Mission Street after a lengthy, emotionally charged hearing that drew several dozen public speakers and multiple community groups.

Steve Curry, president of the Outer Mission Merchants & Residents Association (OMRA), led the appellant’s case, raising procedural objections about notice, alleging the permit contributed to an unacceptable clustering of medical cannabis dispensaries on Mission Street and citing concerns about proximity to schools, childcare and senior facilities. He read and referenced a range of community petitions and a letter from Supervisor John Avalos raising the clustering issue.

Permit holder Eugene Papak and his team presented a detailed security plan, letters of neighborhood and institutional support, and a union‑backed collective bargaining agreement for employees; Mission Organics representatives and outside experts said properly run dispensaries reduce street dealing and can lower crime. Multiple patients and community groups (including UFCW, Americans for Safe Access and neighborhood advocates) testified in favor, citing improved access for patients, accessibility standards and economic opportunities.

Planning staff explained that San Francisco’s planning code restricts dispensary siting based on sensitive uses and land‑use factors but does not currently bar clustering by distance; the Planning Commission had reviewed the case and found it code‑complying. Planning staff also distinguished this case from a prior Taraval decision (which involved an unusually high concentration of sensitive uses nearby) and noted that some childcare facilities cited by the appellant lacked required permits. DBI staff confirmed the site permit went through required interdepartmental review and compliance checks.

Several commissioners acknowledged the community’s concerns and expressed sympathy for residents’ fears about concentration, hours and retail character; some recommended more outreach and bilingual community liaisons. After deliberation, Commissioners (motion by Commissioner O'Tato as recorded) denied the appeal and upheld the permit on the basis that the application complied with the city’s existing codes and was factually distinguishable from the Taraval case. The board vote was 3–1 to uphold the permit.

What happens next: The permit stands; ongoing community oversight, the dispensary’s security plan and proposed community liaison were discussed as mechanisms for follow‑up. The Board of Supervisors has been asked (by some speakers) to consider legislation addressing clustering, and staff said that is a policy matter for supervisors rather than for the appeals board.

Provenance: full hearing on appeal 12‑059 (SEG 2726–SEG 5336).